Page 77 - GTM-4-2
P. 77

Global Translational Medicine                                           Glucosidase and metabolic profiles



            22.  Ikeda H, Matsuo T. A new genetically obese hyperglycemic   glucokinase in glucose homeostasis: A perspective 50 years
               rat (Wistar fatty). Diabetes. 1981;30:1045-1050.   after demonstrating the presence of the enzyme in islets of
                                                                  Langerhans. Front Physiol. 2019;10:148.
               doi: 10.2337/diabetes.30.12.1045
                                                                  doi: 10.3389/fphys.2019.00148
            23.  Zucker  LM,  Zucker  TF.  Fatty,  a  new  mutation  in  the  rat.
               J Heredity. 1961;52(6):275-278.                 36.  Nie N, Hull CH, Jenkins K, Sternbrunner K, Bent D.
                                                                  Statistical Package for the Social Sciences. 2  ed. New York:
                                                                                                 nd
               doi: 10.1093/oxfordjournals.jhered.a107093
                                                                  McGraw Hill.
            24.  Peterson RG, Little LA, Neel MA. WKY Fatty rat as a model
               of obesity and non-insulin-dependent diabetes mellitus.   37.  Page EB. Ordered hypothesis for multiple treatments:
               ILAR J. 1990;32(3):13-15.                          A  significance test for linear ranks.  J  Am Stat Assoc.
                                                                  1963;58(301):216-230.
               doi: 10.1093/ilar.32.3.13
                                                                  doi: 10.1080/01621459.1963.10500843
            25.  Russell JC, Koeslag DG. Jcr:  LA-corpulent Rat: A  strain   38.  Chang GG, Tong L. Structure and function of malic enzymes,
               with spontaneous vascular and myocardial disease. ILAR J.   a new class of oxidative decarboxylases.  Biochemistry.
               1990;32(3):27-32.
                                                                  2003;42:12721-12733.
               doi: 10.1093/ilar.32.3.27
                                                                  doi: 10.1021/bi035251+
            26.  Wu-Peng XS, Chua SC, Okada N, Liu SM, Nicolson M,   39.  Chou BS, Shiau SY. Optimal dietary lipid level for growth of
               Leibel RL. Phenotype of the obese Koletsky (f) rat due to   juvenile hybrid tilapia, Oreochromis niloticus X Oreochromis
               Tyr763Stop mutation in the extracellular domain of the   aureus. Aquaculture. 1996;143(2):185-195.
               leptin receptor (Lepr): Evidence for deficient plasma-to-CSF
               transport of leptin in both the Zucker and Koletsky obese      doi: 10.1016/0044-8486(96)01266-5
               rat. Diabetes. 1997;46(3):513-518.              40.  Sugimoto S, Nakajima H, Kosaka K, Hosoi H. Review:
               doi: 10.2337/diab.46.3.513                         Miglitol has potential as a therapeutic drug against obesity.
                                                                  Nutr Metab. 2015;12:51.
            27.  Michaelis OE IV, Ellwood KC, Tulp OL, Greenwood MR.
               Effect of feeding sucrose or starch diets on parameters of      doi: 10.1186/s12986-015-0048-8
               glucose tolerance in the LA/N-corpulent rat.  Nutr Res.   41.  Boque N, Campion J, Paterman L, et al. Influence of dietary
               1986;6:95-99.                                      macronutrient composition on adiposity and cellularity
               doi: 10.1016/s0271-5317(86)80203-2                 of different fat depots in Wistar rats.  J  Physiol Biochem.
                                                                  2009;65(4):387-395.
            28.  Raabo E, Terkilden TC. On the enzymatic determination of
               blood glucose. Scand J Clin and Lab Invest. 1960;12:402-407.     doi: 10.1007/BF03185934
               doi: 10.3109/00365516009065404                  42.  Scott LJ, Spencer CM. Miglitol: A  review of its therapeutic
                                                                  potential in type 2 diabetes mellitus. Drugs. 2000;59(3):521-549.
            29.  Hales CN, Randle PJ. Immunoassay of insulin and insulin
               antibody precipitate. Biochem J. 1963;88:137-146.     doi: 10.2165/00003495-200059030-00012
               doi: 10.1042/bj0880137                          43.  Coniff  RF,  Shapiro  JA,  Robbins  D,  et al.  Reduction  of
                                                                  glycosylated hemoglobin and postprandial hyperglycemia
            30.  Wallace TM, Levy JC, Mathews DR. Use and abuse of   by acarbose in patients with NIDDM. A placebo-controlled
               HOMA modeling. Diabetes Care. 2004;27(6):1487-1495.
                                                                  dose-comparison study. Diabetes Care. 1995;18(6):817-824.
               doi: 10.2337/diacare.27.6.1487
                                                                  doi: 10.2337/diacare.18.6.817
            31.  Bentzen CJ, Acuff AJ, Marachal MA, Volk ME. Direct   44.  Hanefeld M, Fischer S, Schulze J, et al. Therapeutic potentials
               determination  of  lipoprotein  cholesterol  distribution  with   of acarbose as first-line drug in NIDDM insufficiently
               microscale affinity chromatography columns.  Clin Chem.   treated with diet alone. Diabetes Care. 1991;14(8):732-737.
               1982;28(7):1451-1456.
                                                                  doi: 10.2337/diacare.14.8.732
            32.  Bucolo G, David H. Determination of cholesterol lipoproteins
               via affinity chromatography. Clin Chem. 1973;4:476-481.  45.  Lee J, Lee S, Zhang H, et al. Interaction of IL-6 and TNF-α
                                                                  contributes to endothelial dysfunction in type  2 diabetic
            33.  Freeland RA. Effect of starvation on rat liver enzymes.   mouse hearts. PLoS One. 2017;12(11):e0187189.
               J Nutr. 1987;91:489-495.
                                                                  doi: 10.1371/journal.pone.0187189
               doi: 10.1093/jn/91.4.489
                                                               46.  Ajuwon KM, Spurlock ME. Palmitate activates the NF-κB
            34.  Lowry OH, Rosebrogh NJ, Farr AL, Randall RJ. Measurement   transcription factor and induces IL-6 and TNFα expression
               of proteins in tissues. J Biol Chem. 1951;193:265-275.  in 3T3-L1 adipocytes. J Nutr. 2005;135(8):1841-1846.
            35.  Matschinsky FM, Wilson DF. The Central role of


            Volume 4 Issue 2 (2025)                         69                              doi: 10.36922/gtm.6501
   72   73   74   75   76   77   78   79   80   81   82